The white blood cell as a risk factor for thrombotic vascular disease

Abstract

References

Shaper AG , Pocock SJ , Walker M. , Cohen NM , Wale CJ , Thomson AG British Regional Heart Study: cardiovascular risk factors in middle-aged men in 24 towns. Br Med J 1982; 283: 179-86.

Martin MJ , Halley SB , Browner WS , Kuller LH , Wentworth D. Serum cholesterol, blood pressure and mortality: implications from a cohort of 361,662 men. Lancet 1986; ii: 933-36.

Shaper AG , Pocock SJ , Walker M. , Phillips AM , Whitehead TP , Macfarlane PW Risk factors for ischaemic heart disease: the prospective phase of the British Regional Heart Study. J Epidemiol Community Health 1985; 39: 197-209.

Atherton A. , Born Gvr. Quantitative investigations of the adhesiveness of circulating polymorphonuclear leukocyte to blood vessel walls. J Physiol (Lond) 1972; 222: 447-74.

Schlant RC , Forman S. , Stamler V. , Canner PL The natural history of coronary heart disease: prognostic factors after recovery from myocardial infarction in 2789 men. Circulation 1982; 66: 401-408.

Haines AP , Howarth D. , North WR et al. Haemostatic variables and the outcome of myocardial infarction . Thromb Haemost 1983; 50: 800-803.

Lowe GD , Machado SG , Krol WF , Barton BA , Forbes CD White blood cell count and haematocrit as predictors of coronary recurrence after myocardial infarction. Thromb Haemost 1985; 54: 700-703.

Harlan JM Leukocyte-endothelial interactions. Blood 1985; 65: 513-25.

Mehta J. , Dinerman J. , Mehta P. et al. Neutrophil function in ischaemic heart disease. Circulation 1989; 79: 549-56.

10.

Mehta JL , Nichols WW , Mehta P. Neutrophils as potential participants in acute myocardial ischemia: relevance to reperfusion. JACC 1988; 11: 1309-16.

11.

Terletskaia LM Granulocyte alkaline phosphatase and myeloperoxidase in patients with ischemia heart disease. Vrach Delo 1989; 13: 13-14.

12.

Gill DS , Barradas MA , Fonseca VA , Gracey L. , Dandona P. Increased histamine content in leukocytes and platelets of patients with peripheral vascular disease. Am J Clin Pathol 1988; 89: 622-26.

13.

Belch Jjf. The role of eicosanoids in inflammation. In: Goodacre J , Dick WC eds, Immunopathogenic mechanisms of arthritis, Lancaster: MTP Press 1988: 26-50.

14.

Wargovich T. , Mehta JL , Nichols WW , Pepine CJ , Conti CR Reduction in blood flow in normal and narrowed coronary arteries of dogs by leukotriene C4. J Am Coll Cardiol 1985; 6: 1047-51.

15.

McCord JM Oxygen-derived free radicals in post-ischaemic tissue injury. N Engl J Med 1985; 312: 159-63.

16.

Wang J. , Zhen E. , Guo Z. , Lu Y. Effect of hyperlipidemic serum on lipid peroxidation, synthesis of prostacyclin and thromboxane by cultured endothelial cells: protective effect of anti-oxidants . Free Rad Biol Med 1989; 7: 243-49.

17.

Belch Jjf , Saniabadi A. , Forbes CD The effect of ZK36374 (Iloprost) on white cell behaviour. In: Schror K , Gryglewski RJ eds, Prostacyclins and its stable analogue Iloprost. Berlin: Springer-Verlag, 1986: 97-102.

18.

Boxer LA , Allen JM , Schmidt M. , Yoder M. , Baehner RL Inhibition of polymorphonuclear leukocyte adherence by prostacyclin. J Lab Clin Med 1980; 95: 672-78.

19.

Azizova OA , Panasenko OM , Vol'Nova TV, Vladimirov YA. Free radical lipid oxidation affects cholesterol transfer between lipoproteins and erythrocytes. Free Rad Biol Med 1989; 7: 251-57.

20.

Barrowcliffe TW , Gray E. , Kerry PJ , Gutteridge Jmc. Lipid peroxides, lipoproteins and thrombosis . Life Chemistry Reports 1985; 3: 174-88.

21.

Gryglewski RJ , Palmer Rmj , Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 1987; 320: 454-56.

22.

Singal PK , Beamish RE , Dhalla NS Potential oxidative pathways of catecholamines in the formation of lipid peroxides and genesis of heart disease. Adv Exp Med Biol 1983; 161: 391-401.

23.

Muxfelat M. , Schaper W. The activity of xanthine oxidase in hearts of pigs, guinea pigs, rabbits, rats and humans. Basic Res Cardiol 1987; 82: 486-92.

24.

Roberfroid MB , Viehe HG , Remade J. Free radicals in drug research. Adv Drug Res 1987; 16: 184.

25.

Burton KP Superoxide dismutase enhances recovery following myocardial ischaemia. Am J Physiol 1985 ; 248: 637-43.

26.

Woodward B. , Zaharia MM Effect of some free radical scavengers on reperfusion-induced arrhythmias in the isolated rat heart. J Mol Cell Cardiol 1985; 17: 485-93.

27.

Werns SW , Shea MJ , Driscoll EM et al. The independent effects of oxygen radical scavengers on canine infarct size. Circ Res 1985; 56: 895-98.

28.

Reddy BR , Kloner RA , Przyklenk K. Early treatment with deferoxamine limits myocardial ischaemic/reperfusion injury. Free Rad Biol Med 1989; 7: 45-52.

29.

Belch Jjf , Chopra M. , Hutchinson S. et al. Free radical pathology in chronic arterial disease. Free Rad Biol Med 1989; 6: 396-98.

30.

Chopra M. , Smith WE , Ansell D. , Belch Jjf. Free radical pathology in Raynaud's Phenomenon. Acta Chir Scand 1988; 546S: 51A.

31.

Oldroyd KG , Chopra M. , Rankin AC , Belch Jjf , Cobbe SM Lipid peroxidation during pacing-induced myocardial ischaemia. Br Heart J (in press).

32.

Stringer MD , Gorog PG , Freeman A. , Kakkar VV Lipid peroxides and atherosclerosis. Br Med J 1989; 298: 281-84.

33.

Capecchi PL , Pasini FL , Pasqui AL et al. Allopurinol prevents ischaemia-dependant haemorheological changes. Eur J Clin Pharmacol 1988; 35: 475-87.

34.

Violi F. , Rasura M. , Alessandri C. et al. Leukocyte response in patients suffering from acute stroke. Stroke 1988; 19: 1283-84.

35.

Schmid-Schonbein GW , Engler RL Granulocytes as active participants in acute myocardial ischemia and infarction. Am J Cardiovasc Pathol 1986; vmr-1: 15-30.

36.

Bagge U. , Branemark PI White blood cell rheology. An intra-vital study in man. Adv Microcirc 1977; 7: 1-17.

37.

Mercuri M. , Ciuffetti G. , Robinson M. , Toole J. Blood cell rheology in acute cerebral infarction. Stroke 1989; 20: 959-62.

38.

Vermes I. , Strik F. Altered leukocyte rheology in patients with chronic cerebrovascular disease . Stroke 1989; 19: 631-33.

39.

Ciuffetti G. , Mercuri M. , Lombardini R. , Maragoni G. , Santambrogio L. , Mannarino E. Leukocyte behaviour in controlled ischaemia of the calves. J Clin Pathol 1989; 42: 1083-87.

40.

Nash GB , Christopher B. , Morris Ajr , Dormandy JA Changes in the flow properties of white blood cells after myocardial infarction . Br Heart J 1989; 62: 329-34.

41.

Fisher TC , Belch Jjf , Barbenel JC , Fisher AC In vitro human whole blood granulocyte aggregation. Clin Sci 1989; 76: 183-87.

42.

Mehta J. , Dinerman J. , Mehta P. et al. Neutrophil function in ischaemic heart disease. Circulation 1989; 79: 549-56.

43.

Pfafferott C. , Meiselman HJ , Hochstein P. The effect of malonyldialdehyde on erythrocyte deformability. Blood 1982; 59: 12-15.

44.

Bagge U. , Blixt A. , Strid K-G. The initiation of post-capillary margination of leukocytes: studies in vitro on the influence of erythrocyte concentration and flow velocity. Int J Microcirc 1983; 2: 215-27.

45.

Canoso RT , Rodvien R. , Scoon K. , Levine PH Hydrogen peroxide and platelet function. Blood 1974; 43: 645-56.

46.

Puustinen T. , Uotila P. Thromboxane formation in human polymorphonuclear leukocytes is inhibited by prednisolone and stimulated by leukotrienes B4, C4, D4 and histamine. Prost Leuk Med 1984; 14: 161-68.

47.

Bednar M. , Smith B. , Pinto A. , Mullane KM Neutrophil depletion suppresses indium-III labelled platelet accumulation in infarcted myocardium. J Cardiovasc Pharmacol 1985; 7: 906-12.

48.

Banks DC , Mitchell Jra. Leukocytes and thrombosis. III. Effect on white cell behaviour of substances which induce or inhibit platelet aggregation. Thrombosis, Diathesis and Haemorrhagica 1973; 30: 62-71.

49.

Maclouf J. , Delaclos BF , Borgeat P. Stimulation of leukotriene biosynthesis in human blood leukocytes by platelet derived 12-hydroperoxyicosatetraenoic acid. Proc Natl Acad Sci USA 1982; 79: 6042-46.

50.

Matsuoka M. , Sakuragawa N. , Shimaoka M. Studies on fibrinolytic activities in normal human leucocytes. Acta Med Biol 1969; 16: 91-104.

51.

Varadi K. , Marossy K. , Asboth G. , Elodi P. , Elodi S. Inactivation of human factor VIII by granulocyte proteases. Thromb Haemost 1980; 65: 45-48.

52.

Buchanan MR , Haas TA , Lagarde M. , Guichardant M. 13-hydroxyoctadecadienoic acid is the vessel wall chemorepellant COX. J Biol Chem 1985; 260: 16056-59.

53.

Friedman GD , Klatsky AL , Siegelaub AB The leukocyte count as a predictor of myocardial infarction. N Engl J Med 1974; 290: 1275-78.

54.

Corre F. , Lellouch J. , Schwartz D. Smoking and leucocyte counts. Results of an epidemiologic survey. Lancet 1971; ii: 632-35.

55.

Zalokar JB , Richard JL , Claude JR Leukocyte count, smoking and myocardial infarction. N Engl J Med 1981; 304: 465-68.

56.

Prentice RL , Shimizu Y. , Lin CH et al. Leukocyte counts and coronary heart disease in a Japanese cohort. Am J Empidemiol 1982; 116: 496-506.

57.

Grimm RH , Cohen JD , Smith WM , Falvo-Gerard L. , Neaton JD Hypertension management in the Multiple Risk Factor Intervention Trial (MRFIT). Six-year intervention results for men in special intervention and normal care groups. Arch Intern Med 1985; 145: 1191-99.

58.

Romson JL , Hook BG , Kunkel SL , Abrams GD , Schork MA , Lucchesi BR Reduction of the extent of ischaemic myocardial injury by neutrophil depletion in the dog. Circulation 1983; 67: 1016-23.

59.

Engler RL , Dahlgren MD , Morris DD , Peterson MA , Schmid-Schonbein GW Role of leukocytes in response to acute myocardial ischaemia and reflow in dogs. Am J Physiol 1986; 251: 314-22.

60.

Shoenfeld Y. , Pinkhas J. Leukopenia and low incidence of myocardial infarction. N Engl J Med 1981; 305: 1606.

61.

Kostis JB , Turkevich D. , Sharp J. Association between leukocyte count and the presence and extent of coronary atherosclerosis as determined by coronary arteriography. Am J Cardiol 1984; 53: 997-99.

62.

Kuzuya T. , Hoshida S. , Suzuki K. et al. Polymorphonuclear leukocyte activity and ventricular arrythmia in acute myocardial infarction. Am J Cardiol 1988; 62: 868-72.

63.

Dormandy J. , Nash G. , Thomas P. , Loosemore T. White blood cells and ischaemia. Acta Chir Scand 1988; 546S: 33A.

64.

Prentice RL , Szatrowski TP , Kato H. , Mason MW Leukocyte counts and cerebrovascular disease . J Chron Dis 1982; 35: 703-14.

65.

Lowe Gdo , Jaap AJ , Forbes CD Relation of atrial fibrillation and high haematocrit to mortality in acute stroke. Lancet 1983; i: 784-86.

66.

LaghiPasim F. , Pasqui AL , Ceccatelli L. , Capecchi PL , Orrico A. , DiPerri T. Heparin inhibition of polymorphonuclear leukocyte activation in vitro. A possible pharmacological approach to granulocyte-mediated vascular damage. Thromb Res 1984; 35: 527-37.

67.

Abramson S. , Edelson H. Inhibition of neutrophil activation by non-steroidal antiinflammatory drugs. Am J Med 1984; 77: 3-6.

68.

Tahamont MV , Gee MH The effects of cyclooxygenase inhibition on chemiluminescence and aggregation in sheep neutrophils. Prost Leuk Med 1986; 24: 139-49.

69.

Belch Jjf , McKay A. , McArdle B. et al. A double blind study of the effect of prostacyclin infusion in severe peripheral vascular disease. Lancet 1983; 8320: 315-17.

70.

Mullane KM , Moncada S. The salvage of ischaemic myocardium by BW755C in anaesthetized dogs. Prostaglandins 1983; 24: 255-66.

71.

Chropra M. , McMurray J. , McLay J. et al. Oxidative damage in chronic heart failure. Protection by Captopril through free radical scavenging. In: Emerit I , Packer L , Auclair C , eds, Antioxidants in therapy and preventative medicine. London: Plenum Press (in press).

72.

Chopra M. , Scott N. , Smith WE , Belch Jjf. Captopril: a free radical scavenger. Br J Pharmacol 1989; 27: 396-99.

73.

Parving HH , Hommel E. , Smidt UM Protection of kidney function and clearance in albuminuria by captopril in insulin dependent diabetics with nephropathy. Br Med J 1988; 297: 1086-89.

74.

Cordova C. , Violi F. , Chiselli A. , Alessandri C. , Frattaroli S. In vitro effect of vitamin E and butylated hydroxytoluene on plasma malondialdehyde-like material formation. Thromb Haemost 1986; 55: 296.